Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors with Higher Potency Compared to Human α3β4 and α7 Subtypes
Hugo R. Arias, Dominik Feuerbach, Bernd Schmidt, Matthias Heydenreich, Cristian Paz, Marcelo O. Ortells
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors with Higher Potency Compared to Human α3β4 and α7 Subtypes'. Together they form a unique fingerprint.